JP Morgan Chase
IMNM icon

JP Morgan Chase’s Immunome IMNM Stock Holding History

JP Morgan Chase’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39M Sell
1,848,548
-929,288
-33% -$19.9M ﹤0.01% 1663
2026
Q1 		$53.6M Sell
2,777,836
-77,911
-3% -$1.73M ﹤0.01% 1359
2025
Q4 		$61.3M Buy
2,855,747
+2,823,144
+8,659% +$49.5M ﹤0.01% 1227
2025
Q3 		$382K Sell
32,603
-543,527
-94% -$5.41M ﹤0.01% 5175
2025
Q2 		$5.36M Sell
576,130
-43,408
-7% -$356K ﹤0.01% 3101
2025
Q1 		$4.17M Sell
619,538
-29,072
-4% -$279K ﹤0.01% 3315
2024
Q4 		$6.89M Buy
648,610
+624,045
+2,540% +$7.54M ﹤0.01% 3054
2024
Q3 		$359K Buy
24,565
+1,520
+7% +$21.6K ﹤0.01% 5108
2024
Q2 		$279K Buy
23,045
+22,317
+3,066% +$349K ﹤0.01% 4974
2024
Q1 		$18K Sell
728
-17,574
-96% -$357K ﹤0.01% 6252
2023
Q4 		$196K Buy
+18,302
New +$152K ﹤0.01% 5398
2023
Q3 		– Sell
-915
Closed -$7.24K – 7588
2023
Q2 		$7.24K Buy
+915
New +$5K ﹤0.01% 6107
2021
Q3 		– Sell
-768
Closed -$13K – 6639
2021
Q2 		$13K Sell
768
-5,089
-87% -$112K ﹤0.01% 6000
2021
Q1 		$198K Buy
5,857
+126
+2% +$3.13K ﹤0.01% 5152
2020
Q4 		$55K Buy
+5,731
New +$66.8K ﹤0.01% 5133

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

JP Morgan Chase's IMNM Position: Q2 2026 in Review

JP Morgan Chase reduced its Immunome (IMNM) stake by 33% in Q2 2026, selling an estimated $19.9M and leaving 1,848,548 shares worth $39M. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

JP Morgan Chase first reported a position in IMNM in Q4 2020 and has held it in 15 quarters since. The position peaked at $61.3M in Q4 2025. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • JP Morgan Chase held 1,848,548 shares of Immunome worth $39M as of Q2 2026.
  • JP Morgan Chase sold 929,288 Immunome shares in Q2 2026, an estimated $19.9M.
  • Immunome made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1663 holding.
  • JP Morgan Chase first reported a position in Immunome in Q4 2020 and has held it in 15 quarters since.
  • JP Morgan Chase's Immunome position peaked at $61.3M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.